MAGEA3 Produits
(Melanoma Antigen Family A, 3 (MAGEA3))
Catégories
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories MAGEA3 en vedette
MAGEA3 Anticorps
High quality antibodies with extensive validation data.
MAGEA3 Kits ELISA
Reliable ELISA kits for a wide range of species.
MAGEA3 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
MAGEA3 recommandé Anticorps
- (3)
- (3)
- (1)
- (3)
- (3)
MAGEA3 recommandé Kits ELISA
- (1)
- (1)
MAGEA3 recommandé Protéines
- (1)
- (1)
- (1)
Dernières publications sur nos produits MAGEA3
: "Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial ..." dans: Urologia internationalis, Vol. 102, Issue 1, pp. 77-82, (2019) (PubMed).: "MicroRNA-874 Functions as a Tumor Suppressor by Targeting Cancer/Testis Antigen HCA587/MAGE-C2." dans: Journal of Cancer, Vol. 7, Issue 6, pp. 656-63, (2016) (PubMed).
: "Absence of recognition of common melanocytic antigens by T cells isolated from the cerebrospinal fluid of a Vogt-Koyanagi-Harada patient." dans: Molecular vision, Vol. 20, pp. 956-69, (2014) (PubMed).
: "Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma." dans: International journal of clinical and experimental pathology, Vol. 7, Issue 7, pp. 4112-9, (2014) (PubMed).
: "?-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial." dans: BMC cancer, Vol. 12, pp. 623, (2013) (PubMed).
: "MAGE-C1/CT7 is the dominant cancer-testis antigen targeted by humoral immune responses in patients with multiple myeloma." dans: Leukemia, Vol. 22, Issue 8, pp. 1646-8, (2008) (PubMed).
: "The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 13, Issue 16, pp. 4713-20, (2007) (PubMed).
: "MAD-CT-2 identified as a novel melanoma cancer-testis antigen using phage immunoblot analysis." dans: Journal of immunotherapy (Hagerstown, Md. : 1997), Vol. 30, Issue 7, pp. 675-83, (2007) (PubMed).
Synonymes et noms alternatifs relatifs à MAGEA3
MAGE family member A3 (MAGEA3), melanoma antigen, family A, 3 (Magea3), melanoma antigen family A, 3 (MAGEA3), CT1.3, HIP8, HYPD, Mage-a3, MAGE3, MAGEA3, MAGEA6Protein level used designations for MAGEA3
- MAGE-3 antigen
- antigen MZ2-D
- cancer/testis antigen 1.3
- cancer/testis antigen family 1, member 3
- melanoma-associated antigen 3
- melanoma antigen family A, 3